Anti-Cancer Activity of Catechin against A549 Lung Carcinoma Cells by Induction of Cyclin Kinase Inhibitor p21 and Suppression of Cyclin E1 and P–AKT

Expression of pAkt is associated with a poor prognosis in Chinese women with invasive ductal breast cancer

(2018) Ling Zhou et al.   Oncology Letters

The crucial role of protein phosphorylation in cell signaling and its use as targeted therapy (Review)

(2017) Fatima Ardito et al.   INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE

An overview on the role of dietary phenolics for the treatment of cancers

(2016) Preethi G. Anantharaju et al.   Nutrition Journal

Glycyrrhetinic acid induces G1-phase cell cycle arrest in human non-small cell lung cancer cells through endoplasmic reticulum stress pathway

(2015) JIE ZHU et al.   INTERNATIONAL JOURNAL OF ONCOLOGY

Epigallocatechin-3-Gallate Enhances the Therapeutic Effects of Leptomycin B on Human Lung Cancer A549 Cells

(2015) Meghan M. Cromie et al.   Oxidative Medicine and Cellular Longevity

Clinical significance of pAkt and pErk1/2 expression in early-stage breast cancer patients treated with anthracycline-based adjuvant chemotherapy

(2015) WENJUAN LIU et al.   Oncology Letters

Targeting Cyclin-Dependent Kinases in Human Cancers: From Small Molecules to Peptide Inhibitors

(2015) Marion Peyressatre et al.   Cancers

Inhibition of human lung cancer cell proliferation and survival by wine

(2014) Carly C Barron et al.   Cancer Cell International

Effects of Epigallocatechin-3-gallate (EGCG) on A549 Lung Cancer Tumor Growth and Angiogenesis

(2013) Yuhi SAKAMOTO et al.   BIOSCIENCE BIOTECHNOLOGY AND BIOCHEMISTRY

MiR-15a is underexpressed and inhibits the cell cycle by targeting CCNE1 in breast cancer

(2013) QIFENG LUO et al.   INTERNATIONAL JOURNAL OF ONCOLOGY

Anti-cancer potential of flavonoids: recent trends and future perspectives

(2013) Priya Batra et al.   3 Biotech

Cell cycle-related kinase in carcinogenesis

(2012) YE TIAN et al.   Oncology Letters

Green tea catechin, epigallocatechin-3-gallate (EGCG): Mechanisms, perspectives and clinical applications

(2011) Brahma N. Singh et al.   BIOCHEMICAL PHARMACOLOGY

Cytoplasmic p21 is a potential predictor for cisplatin sensitivity in ovarian cancer

(2011) Xi Xia et al.   BMC CANCER

p27: A Barometer of Signaling Deregulation and Potential Predictor of Response to Targeted Therapies

(2010) S. A. Wander et al.   CLINICAL CANCER RESEARCH

The Green Tea Polyphenol EGCG Potentiates the Antiproliferative Activity of c-Met and Epidermal Growth Factor Receptor Inhibitors in Non-small Cell Lung Cancer Cells

(2009) S. A. Milligan et al.   CLINICAL CANCER RESEARCH

Pathogenesis of lung cancer signalling pathways: roadmap for therapies

(2009) E. Brambilla et al.   EUROPEAN RESPIRATORY JOURNAL